Cargando…

Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases

OBJECTIVE: To explore the mechanism and safety of bisphosphonates in patients with lung cancer and bone metastases. METHOD: A total of 104 patients with lung cancer and bone metastases in our hospital were selected and randomly divided into two groups: control group (n = 54) and research group (n =...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Gao, Gong, Hu, Xu, Hanqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687786/ https://www.ncbi.nlm.nih.gov/pubmed/34938354 http://dx.doi.org/10.1155/2021/5343104

Ejemplares similares

Retracted: Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988)

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer
por: Hagiwara, May, et al.
Publicado: (2013)

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010)

Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials
por: WANG, XIN, et al.
Publicado: (2014)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
por: Addison, Christina L, et al.
Publicado: (2014)

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
por: Pfannkuchen, Nina, et al.
Publicado: (2017)

Effects of palliative radiotherapy and bisphosphonate usage on bone turnover marker levels in cancer patients with osteolytic bone metastases
por: Göksel, Fatih, et al.
Publicado: (2021)

Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
por: Diel, Ingo, et al.
Publicado: (2020)

Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.
por: Dodwell, D. J., et al.
Publicado: (1990)

What are the efficacy and safety of bisphosphonates and RANK-ligand-inhibitors for men with prostate cancer and bone metastases? - A Cochrane Review summary with commentary
por: Moretti, Antimo
Publicado: (2021)

Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases
por: Zhang, Guowei, et al.
Publicado: (2017)

Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases
por: Park, In Hae, et al.
Publicado: (2009)

Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy
por: Holt, Abby, et al.
Publicado: (2014)

Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases
por: Matza, Louis S., et al.
Publicado: (2012)

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
por: Coleman, R. E., et al.
Publicado: (1988)

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
por: Beuselinck, B, et al.
Publicado: (2012)

Efficacy and safety of nintedanib in patients with non-small cell lung cancer, and novel insights in radiation-induced lung toxicity
por: Yan, Shu, et al.
Publicado: (2023)

Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
por: Walls, J., et al.
Publicado: (1994)

Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer
por: Zhang, Li, et al.
Publicado: (2017)

Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Hu, Yan, et al.
Publicado: (2017)

Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis
por: Gong, Linlin, et al.
Publicado: (2019)

Bisphosphonates in the Treatment of Patients With Metastatic Breast, Lung, and Prostate Cancer: A Meta-Analysis
por: Liu, Jing, et al.
Publicado: (2015)

Targeted Treatments of Bone Metastases in Patients with Lung Cancer
por: Hirsh, Vera
Publicado: (2014)

Incidence and consequences of bone metastases in lung cancer patients
por: Kuchuk, Michael, et al.
Publicado: (2013)

The risk factors of bone metastases in patients with lung cancer
por: Zhou, Yang, et al.
Publicado: (2017)

The role of bisphosphonates in breast cancer: Development of bisphosphonates
por: Fleisch, Herbert
Publicado: (2002)

Efficacy and safety of de-escalation bone- modifying agents for cancer patients with bone metastases: a systematic review and meta-analysis
por: Liu, Cun, et al.
Publicado: (2018)

Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis
por: Yao, Liwei, et al.
Publicado: (2017)

Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment
por: Razaq, Abdul, et al.
Publicado: (2019)

Subtrochanteric Femoral Insufficiency Fracture Following Bisphosphonate Therapy for Osseous Metastases
por: Bush, Lisabeth A., et al.
Publicado: (2015)

Is De-escalated Bisphosphonates Therapy a Suitable Alternative to Standard Dosing in Malignant Tumor Patients With Bone Metastases: A Systematic Review and Meta-Analysis
por: Luo, Qiuhua, et al.
Publicado: (2019)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Bisphosphonate conjugation for bone specific drug targeting
por: Farrell, Kristen B., et al.
Publicado: (2018)

Prostate Cancer and Bone Metastases: The Underlying Mechanisms
por: Wong, Sok Kuan, et al.
Publicado: (2019)

Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
por: Shupp, Alison B., et al.
Publicado: (2018)

The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation
por: Radeczky, Peter, et al.
Publicado: (2021)

Bisphosphonates and risk of lung cancer: Protocol for a systematic review and meta-analysis
por: Li, Minghao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jrg21bfoio19799245v6ssid17